Skip to search formSkip to main contentSkip to account menu

FIGF gene

Known as: VASCULAR ENDOTHELIAL GROWTH FACTOR D, c-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) Gene, VEGFD 
This gene plays a role in angiogenesis, lymphangiogenesis, and endothelial cell growth.
National Institutes of Health

Related topics

Related topics

9 relations
Angiogenic ProcessCell Proliferation Regulatory ProcessChemotaxisFIGF protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Pulmonary Vasculopathy Associated with FIGF Gene Mutation.
2017
2017
Proteolytic Activation by ADAMTS3 Defines Distinct Mechanisms of Lymphangiogenesis Mediated By VEGFC And VEGFD
Lymphangiogenesis is supported by two homologous VEGFR3 ligands, VEGFC and VEGFD. VEGFC is required for lymphatic development… 
Review
2016
Review
2016
Lymphangiogenic and Chemotactic Factors in Conjunctival Melanoma
Purpose: The aim of this study was to evaluate expression patterns of known lymphangiogenic growth factors and chemokines in… 
2014
2014
Expression and localization of locally produced growth factors regulating lymphangiogenesis during different stages of the estrous cycle in corpus luteum of buffalo (Bubalus bubalis).
2013
2013
Abstract 369: Role of bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.
Background: Based on bone marrow (BM) biopsies, increased angiogenesis has been reported in multiple myeloma (MM) and smoldering… 
2012
2012
Localization of C-Fos-Induced Growth Factor (Figf) mRNA Expression in the Mouse Uterus during Implantation
The purpose of this study was to characterize the localization of Figf mRNA in the mouse uterus during embryo implantation… 
2011
2011
Does overexpression of VEGFR and TIMP2 predict survival in primary cervical cancer (CC) patients? Results of a companion protocol of the randomized, phase III adjuvant trial of simultaneous cisplatin…
e15507 Background: Aim of the study was to analyse the expression-profile of IGF1, IGFBP3, sICAM1, sVCAM1, MMP2, MMP9, TIMP2… 
2011
2011
Abstract 4266: Acquired resistance to sorafenib yields CXCL12 (SDF1α) over-expression and increases invasion in hepatocarcinoma cells
Background: Sorafenib has a well known efficacy in patients with advanced hepatocellular carcinoma (HCC). Sorafenib displays… 
2011
2011
Abstract 5138: Expression and circulating levels of VEGFC/VEGFD and their receptor VEGFR2, R3 in renal cell cancer: Relationship with clinicopathological parameters
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Vascular endothelial growth factors C, VEGF… 
2000
2000
A role of free insulin-like growth factor-I in dawn phenomenon in children and adolescents with type 1 diabetes mellitus.
It has been hypothesized that a decreased amount of the free form of insulin-like growth factor-I (fIGF-I) results in morning… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)